Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study

OBJECTIVE: To monitor the hematologic modifications in the peripheral blood of patients with relapsing-remitting multiple sclerosis treated with natalizumab. METHODS: The cohort included 44 patients with relapsing-remitting multiple sclerosis treated monthly with natalizumab for 18 months. Periphera...

Descripción completa

Detalles Bibliográficos
Autores principales: Bridel, Claire, Beauverd, Yan, Samii, Kaveh, Lalive, Patrice H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476051/
https://www.ncbi.nlm.nih.gov/pubmed/26140281
http://dx.doi.org/10.1212/NXI.0000000000000123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476051/
https://www.ncbi.nlm.nih.gov/pubmed/26140281
http://dx.doi.org/10.1212/NXI.0000000000000123

Ejemplares similares